Day: March 21, 2025

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 21, 2025 (GLOBE NEWSWIRE) — Outcrop Silver & Gold Corporation (TSXV: OCG) (OTCQX: OCGSF) (DE: MRG) (“Outcrop Silver” or the “Company”) is pleased to announce that, due to strong investor demand, it has increased the size of its previously announced public offering of units of the Company (the “Units”) for aggregate gross proceeds of up to $6,500,000 (the “Offering“) at a price of $0.22 per Unit. The Offering is being led by Research Capital as sole agent and sole bookrunner (the “Agent”). Mr. Eric Sprott, through 2176423 Ontario Ltd., has indicated his intention to participate in the Offering. Each Unit will be comprised of one common share of the Company (a “Common Share“)...

(2025-03-21) Enclosed is a pdf version of the 2024 Annual Report for Kitron ASA. The Annual Report is also available on our website, www.kitron.com. The company publishes its annual financial statements also in European Single Electronic Format (ESEF), available as an attachment to this release. For further information, please contact: Cathrin Nylander, CFO, tel. +47 900 43 284 E-mail: investorrelations@kitron.com Kitron is a leading Scandinavian electronics manufacturing services company for the Connectivity, Electrification, Industry, Medical devices and Defence/Aerospace sectors. The group has operations located in Norway, Sweden, Denmark, Lithuania, Germany, Poland, the Czech Republic, India, Malaysia, China and the United States. Kitron has about 2 400 employees, and revenues were EUR 647 million in 2024. www.kitron.com This information...

CAPGEMINISociété Européenne (European Company) with a share capital of €1,370,779,768Registered office at 11, rue de Tilsitt, 75017 Paris (France)330 703 844 RCS Paris Paris, March 21, 2025. Combined Shareholders’ Meeting on May 7th, 2025 Availability of documents relating to the General Meeting The Capgemini SE Combined Shareholders’ Meeting will be held on Wednesday, May 7, 2025 at 2 p.m. CET at Pavillon Gabriel, 5 avenue Gabriel, Paris (8th District). Documents and information relating to the General Meeting are available on the website of the Company: https://investors.capgemini.com/en/event/2025-shareholders-meeting/. The Shareholders’ Meeting will be subject, in its entirety, of a live audiovisual broadcasting via the link above. A recording of the Shareholders’ Meeting will be available for consultation on the Company’s website...

Lannion, March 21, 2025– 5:45pm LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2025 LUMIBIRD’s shareholders are informed that they are invited to take part in the Combined General Meeting to be held on Tuesday, April 29th, 2025 from 2:00pm (CET) at 15 rue du Zéphyr, ZA de Courtabœuf, 91140 VILLEJUST- France. The meeting notice containing the agenda, the text of the resolutions and the main conditions for taking part in and voting at the General Meeting was published in the French official gazette (Bulletin des Annonces Légales Obligatoires, BALO) on March 19, 2025 (Bulletin no.34/ Notice no. 2500690). It can be downloaded from LUMIBIRD’s website at www.lumibird.com and the BALO site at balo.journal-officiel.gouv.fr. Shareholders are invited to vote by post or email or by proxy using the dedicated...

CAPGEMINISociété Européenne (European Company) with a share capital of €1,370,779,768Registered office at 11, rue de Tilsitt, 75017 Paris (France)330 703 844 RCS Paris Paris, March 21, 2025. Publication of the 2024 Universal Registration Document Capgemini SE filed today with the French Financial Markets Authority (AMF) its 2024 Universal Registration Document (“Document d’Enregistrement Universel”), which does include the following documents:the 2024 annual financial report, including the management report and in particular the sustainability information and the report on the certification of this information, the report of the Board of Directors on corporate governance and the observations of the auditors thereon, the share buyback program description.The abovementioned French version of the 2024 Universal Registration Document...

Engineered to help gamers win – The H3 Wireless is carefully optimized for gaming, amplifying crucial in-game sounds to give players a competitive advantage, especially in FPS games. Precise sound for every situation – whether gaming, music or movies, the H3 Wireless offers multiple EQ modes, with both low-latency wireless and Bluetooth compatibility for seamless connectivity across devices. Lightweight & comfortable – The robust aluminum construction combined with soft over-ear cushions adapt perfectly to the shape of the head and ensure long-lasting comfort. Long-lasting battery life – With up to 100 hours of continuous use, the H3 Wireless lasts an extremely long time and can be conveniently charged via USB-C.The CHERRY XTRFY H3 Wireless gaming headset delivers high-performance audio with dual wireless connectivity, customizable...

The board of INVL Baltic Farmland, AB, a company investing in agricultural land, approved its activity forecasts for 2025. Consolidated revenues of INVL Baltic Farmland are forecasted at EUR 890 thousand and net profit should amount to EUR 460 thousand. These predictions are based on the assumption that during 2025 the value of the Company’s land holdings will not change. Also there will be no purchases or sales of land, and there will be no changes in provisions for receivables and no impact of tenant debts on the size of the administration fee. INVL Baltic Farmland and its subsidiaries own approximately 3,000 hectares of agricultural land in Lithuania which is rented out to agriculture companies and farmers. Additional information: INVL Baltic Farmland, a company that invests in agricultural land, announced its operating forecasts for...

RESEARCH TRIANGLE PARK, N.C., March 21, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other ophthalmic disorders, today announced that a presentation featuring the LYNX-1 Phase 3 study of Phentolamine Ophthalmic Solution 0.75% in patients with dim light disturbances will be delivered this week at World Cornea Congress IX, taking place March 20-22, 2025 in Washington, D.C. Key highlights from the presentationAs previously reported, the LYNX-1 Phase 3 study met its primary endpoint, with a statistically significant greater percentage of Phentolamine Ophthalmic Solution 0.75%-treated participants gaining 15 or more letters of mesopic low contrast distance visual acuity...

We hereby inform you about the decisions adopted at the Ordinary General Meeting of Shareholders of Urbo Bankas UAB for 2025 (office address: Konstitucijos pr. 18B, Vilnius, company registration number 112027077, VAT number LT120270716) which was held on 21 March 2025 (please see the attached documents). For more information please contact: Julius Ivaška, Head of Business Division, tel. +370 601 04 453, e-mail media@urbo.ltAttachments1 annex_uaburbobankas-2024-12-31_financial statements2 annex_ independent auditors’s report3 annex_allocation of profit for 20244 annex_Urbo banko Article of AssociationResoliutions EN